Stay updated on Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2; the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-15T20:36:04.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-08T20:39:16.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details and associated documents with a minimal error view; a Home link is shown on the error page.
    Difference
    18%
    Check dated 2026-09-24T20:54:56.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, indicating a new release of the page's underlying software. This deployment reflects behind-the-scenes changes rather than edits to the study details.
    Difference
    0.0%
    Check dated 2026-09-17T22:07:42.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Tel Litwinsky, Israel, 52621 was added to the study locations, and Qiryat Krinitzi, Israel, 52621 was removed. This update changes the set of sites where participants may enroll and receive trial-related procedures.
    Difference
    0.1%
    Check dated 2026-09-10T21:57:50.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The study locations were updated by adding Qiryat Krinitzi, Israel, 52621 and removing Tel Litwinsky, Israel, 52621, thereby altering the geographic options for potential participants.
    Difference
    0.1%
    Check dated 2026-09-03T19:16:57.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.